KR20240107319A - Trem 조성물 및 사용 방법 - Google Patents

Trem 조성물 및 사용 방법 Download PDF

Info

Publication number
KR20240107319A
KR20240107319A KR1020247015828A KR20247015828A KR20240107319A KR 20240107319 A KR20240107319 A KR 20240107319A KR 1020247015828 A KR1020247015828 A KR 1020247015828A KR 20247015828 A KR20247015828 A KR 20247015828A KR 20240107319 A KR20240107319 A KR 20240107319A
Authority
KR
South Korea
Prior art keywords
trem
modification
naturally occurring
domain
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247015828A
Other languages
English (en)
Korean (ko)
Inventor
테오니 아나스타시아디스
데이비드 찰스 도넬 버틀러
닐 쿠비카
칭이 리
니콜라이 나리쉬킨
아르망 가티엔 고우누 웨티
스테판 윌리엄 에이혼
윌리엄 에프. 키즈만
크리스토퍼 이. 아르케디아
홍추안 유
Original Assignee
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 filed Critical 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨
Publication of KR20240107319A publication Critical patent/KR20240107319A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
KR1020247015828A 2021-10-13 2022-10-13 Trem 조성물 및 사용 방법 Pending KR20240107319A (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163255426P 2021-10-13 2021-10-13
US202163255420P 2021-10-13 2021-10-13
US63/255,426 2021-10-13
US63/255,420 2021-10-13
US202163284946P 2021-12-01 2021-12-01
US202163284934P 2021-12-01 2021-12-01
US63/284,934 2021-12-01
US63/284,946 2021-12-01
PCT/US2022/046632 WO2023064513A2 (en) 2021-10-13 2022-10-13 Trem compositions and methods of use

Publications (1)

Publication Number Publication Date
KR20240107319A true KR20240107319A (ko) 2024-07-09

Family

ID=85987785

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247015828A Pending KR20240107319A (ko) 2021-10-13 2022-10-13 Trem 조성물 및 사용 방법

Country Status (11)

Country Link
US (1) US20240401047A1 (cg-RX-API-DMAC7.html)
EP (1) EP4416288A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024538097A (cg-RX-API-DMAC7.html)
KR (1) KR20240107319A (cg-RX-API-DMAC7.html)
CN (1) CN120418430A (cg-RX-API-DMAC7.html)
AU (1) AU2022362286A1 (cg-RX-API-DMAC7.html)
CA (1) CA3235264A1 (cg-RX-API-DMAC7.html)
IL (1) IL311867A (cg-RX-API-DMAC7.html)
MX (1) MX2024004568A (cg-RX-API-DMAC7.html)
TW (1) TW202325313A (cg-RX-API-DMAC7.html)
WO (1) WO2023064513A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080866A1 (en) * 2023-10-10 2025-04-17 Hc Bioscience, Inc. Trna therapeutics for hemophilia
CN117805381B (zh) * 2024-02-29 2024-05-28 首都医科大学附属北京积水潭医院 检测Gasdermin蛋白家族的物质在制备检测骨肉瘤的产品中的应用
WO2026073261A1 (en) * 2024-09-30 2026-04-02 Flagship Pioneering Innovations Vi, Llc Lipid nanoparticle formulations of trems
WO2026080471A2 (en) * 2024-10-07 2026-04-16 Flagship Pioneering Innovations Vi, Llc Compositions of trem conjugates and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679147B2 (ja) * 2008-02-07 2015-03-04 独立行政法人理化学研究所 非天然塩基を含む改変tRNA及びその用途
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用
JP7712270B2 (ja) * 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
WO2021142343A1 (en) * 2020-01-09 2021-07-15 The Regents Of The University Of California Targeting transfer rna for the suppression of nonsense mutations in messenger rna
BR112022020780A2 (pt) * 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
KR20230135585A (ko) * 2020-12-23 2023-09-25 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 변형된 trem의 조성물 및 이의 용도

Also Published As

Publication number Publication date
US20240401047A1 (en) 2024-12-05
AU2022362286A1 (en) 2024-05-02
TW202325313A (zh) 2023-07-01
MX2024004568A (es) 2024-06-28
WO2023064513A9 (en) 2024-08-02
JP2024538097A (ja) 2024-10-18
WO2023064513A3 (en) 2023-06-15
CN120418430A (zh) 2025-08-01
WO2023064513A2 (en) 2023-04-20
EP4416288A2 (en) 2024-08-21
IL311867A (en) 2024-06-01
CA3235264A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
AU2021255583A1 (en) Trem compositions and uses thereof
JP4764426B2 (ja) カチオン性脂質および使用方法
EP4416288A2 (en) Trem compositions and methods of use
US20060051405A1 (en) Compositions for the delivery of therapeutic agents and uses thereof
WO2021243290A1 (en) Trem compositions and methods relating thereto
KR20230135585A (ko) 변형된 trem의 조성물 및 이의 용도
EP4522743A1 (en) Trem compositions and methods of use for treating proliferative disorders
EP4158032A2 (en) Trem compositions and methods relating thereto
AU2024249959A1 (en) Trem compositions and methods of use
JP2026514004A (ja) 修飾されたtrem、組成物及びその関連方法
WO2026080471A2 (en) Compositions of trem conjugates and uses thereof
WO2024216128A1 (en) Trems for use in correction of missense mutations
CN117083383A (zh) 经修饰的trem的组合物及其用途

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000